Plus Therapeutics Inc Inc. (PSTV) Price Performance: The Role of Supply and Demand

Depending on how one views it, the stock price performance for the year has been a mixed bag, resulting in either an optimistic or pessimistic outlook. The metric has seen a significant loss of -82.30% since the start of this calendar year. Looking back over the last six months, we can see a stronger performance of -71.98%. Over the past 30 days, the price of PSTV has fallen by 1.91%. And in the last five days, it has surged by 11.91%.

The stock of Plus Therapeutics Inc (PSTV) is currently priced at $0.34. In the last session, the stock climbed significantly, topping out at $20.5 after opening at $0.34. The day’s lowest price was $3.0 before the stock closed at $0.36.

Plus Therapeutics Inc experienced a rather shaky stock market performance. The highest value in the past year was recorded at $2.31 on 03/07/25 and the lowest value was $0.16 on 06/18/25.

52-week price history of PSTV Stock

Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Plus Therapeutics Inc’s current trading price is -85.44% away from its 52-week high, while its distance from the 52-week low is 105.81%. The stock’s price range during this period has varied between$0.16 and $2.31. The Plus Therapeutics Inc’s shares, which operate in the Healthcare, saw a trading volume of around 5.52 million for the day, a figure considerably lower than their average daily volume of 26.95 million over last three months.

Market Capitalization vs. Financial Performance: A Comparative Study

Plus Therapeutics Inc (PSTV) has experienced a quarterly decline of -57.27% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 17.15M and boasts a workforce of 21 employees.

Plus Therapeutics Inc: Analysts’ Ratings Unveiled

As of right now, 1 analyst is rating Plus Therapeutics Inc as a BUY, 2 of the polled analysts branded the stock as an OVERWEIGHT, 1 analyst is recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.

Combining Moving Average and Trading Volume Data for Better Market Insight

Based on Barchart.com data, the company’s moving average over the 100-day period was 0.6491, with a change in price of -0.8437. Similarly, Plus Therapeutics Inc recorded 26,351,471 in trading volume during the last 100 days, posting a change of -71.50%.

PSTV Stock Stochastic Average

As of today, Plus Therapeutics Inc’s raw stochastic average for the last 50 days stands at 29.69%. This is a decline compared to the raw stochastic average of the previous 20 days, which was noted at 63.66%. Furthermore, the company’s Stochastic %K and %D values for the past 20 days were 68.34% and 68.60%, respectively.

Invest Chronicle
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.